Keyphrases
Population-based Longitudinal Study
50%
Cognitive Function
50%
Adjuvant Therapy
50%
Early Breast Cancer
50%
Adjuvant Chemotherapy
30%
Chemotherapy
20%
Breast Cancer Patients
20%
Neuropsychological Tests
20%
Patient-rated
10%
Perceived Cognitive Function
10%
Medical Treatment
10%
Cognitive Side Effects
10%
Healthy Controls
10%
Adjuvant Tamoxifen
10%
Psychological Distress
10%
Concurrent Cancer
10%
Denmark
10%
Epirubicin
10%
Jutland
10%
Quality of Life
10%
Cyclophosphamide
10%
Population-based Study
10%
Psychology
Cognitive Function
100%
Breast Cancer
100%
Quality of Life
60%
Longitudinal Study
50%
Psychological Distress
40%
Tamoxifen
30%
Psychological Well-Being
10%
Cognitive Impairment
10%
Cognitive Functioning
10%